Problem List Suggestion for Asthma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Asthma+16 More
Problem List Suggestion - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is designed to improve care for patients with heart, lung and blood conditions by facilitating more accurate and complete problem list documentation.

Eligible Conditions
  • Asthma
  • Sleep Apnea
  • Congestive Heart Failure (CHF)
  • Coronary Artery Disease
  • Smoking
  • Lipidemia
  • Atrial Fibrillation
  • Chronic Obstructive Airway Disease
  • Hypertension
  • Tuberculosis
  • Anemia, Sickle Cell
  • Myocardial Infarction
  • Stroke

Treatment Effectiveness

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: Through study completion, or up to 1 year

Year 1
Determining the effect of problem list completion by comparing the number of study-related problems added to problem lists in the electronic health record
Determining the quality of care impact of adding suggested problems to the problem list based on 4 outcome measures from NCQA's HEDIS 2013 measure set
Evaluating process measures using key process measures for each study condition from CMS, NHLBI, and NQMC
Measuring the rate of acceptance of alerts calculated by number of acceptances for each alert divided by the total number of unique presentations of the alert

Trial Safety

Trial Design

2 Treatment Groups

Normal Use of EHR
1 of 2
Intervention Arm
1 of 2
Active Control
Experimental Treatment

2386 Total Participants · 2 Treatment Groups

Primary Treatment: Problem List Suggestion · No Placebo Group · N/A

Intervention Arm
Other
Experimental Group · 1 Intervention: Problem List Suggestion · Intervention Types: Other
Normal Use of EHRNoIntervention Group · 1 Intervention: Normal Use of EHR · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, or up to 1 year

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,468 Previous Clinical Trials
9,701,268 Total Patients Enrolled
40 Trials studying Asthma
213,490 Patients Enrolled for Asthma
Geisinger ClinicOTHER
134 Previous Clinical Trials
4,920,487 Total Patients Enrolled
1 Trials studying Asthma
15 Patients Enrolled for Asthma
Vanderbilt UniversityOTHER
682 Previous Clinical Trials
6,129,010 Total Patients Enrolled
6 Trials studying Asthma
388 Patients Enrolled for Asthma
Oregon Health and Science UniversityOTHER
885 Previous Clinical Trials
6,826,155 Total Patients Enrolled
2 Trials studying Asthma
660 Patients Enrolled for Asthma

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 19th, 2021

Last Reviewed: October 10th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References